Treatment of diffuse large B-cell lymphoma with and without anthracyclines and rituximab in patients older than 60 years: 10-year results at a Latin American center

Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?

(2017) Bennett E Levis et al.   LANCET ONCOLOGY

R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma

(2016) Kamel Laribi et al.   ANNALS OF HEMATOLOGY

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Non-Hodgkin Lymphomas: Impact of Rituximab on Overall Survival of Patients with Diffuse Large B-Cell and Follicular Lymphoma

(2015) José Carlos Jaime-Pérez et al.   ARCHIVES OF MEDICAL RESEARCH

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

(2014) Bruce D. Cheson et al.   JOURNAL OF CLINICAL ONCOLOGY

B cell non-Hodgkin’s lymphoma: experience from a tertiary care cancer center

(2012) Gaurav Prakash et al.   ANNALS OF HEMATOLOGY

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

(2011) E. Campo et al.   BLOOD